[go: up one dir, main page]

RU95104936A - INJECTION PRODUCT AND INJECTION KIT CONTAINING OMEPRAZOLE AND ITS ANALOGUES - Google Patents

INJECTION PRODUCT AND INJECTION KIT CONTAINING OMEPRAZOLE AND ITS ANALOGUES

Info

Publication number
RU95104936A
RU95104936A RU95104936/14A RU95104936A RU95104936A RU 95104936 A RU95104936 A RU 95104936A RU 95104936/14 A RU95104936/14 A RU 95104936/14A RU 95104936 A RU95104936 A RU 95104936A RU 95104936 A RU95104936 A RU 95104936A
Authority
RU
Russia
Prior art keywords
injection
salt
aqueous solvent
methylsulfinyl
pyridyl
Prior art date
Application number
RU95104936/14A
Other languages
Russian (ru)
Other versions
RU2126252C1 (en
Inventor
Наканиси Сигео
Томинага Тецуо
Яманата Ивао
Хиго Такаси
Сибата Тосийюки
Original Assignee
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астра Актиеболаг filed Critical Астра Актиеболаг
Priority claimed from PCT/JP1993/000998 external-priority patent/WO1994002141A1/en
Publication of RU95104936A publication Critical patent/RU95104936A/en
Application granted granted Critical
Publication of RU2126252C1 publication Critical patent/RU2126252C1/en

Links

Claims (5)

1. Препарат для инъекций, содержащий 2-[(2-пиридил) метилсульфинил]бензимидазольное соединение или его соль, обладающие противоязвенной активностью, отличающийся тем, что содержит водный растворитель без добавок неводного растворителя, причем pH препарата для инъекций не менее 9,5 и не более 11,5.1. An injection preparation containing 2 - [(2-pyridyl) methylsulfinyl] benzimidazole compound or a salt thereof having antiulcer activity, characterized in that it contains an aqueous solvent without additives of non-aqueous solvent, wherein the pH of the injection preparation is not less than 9.5 and no more than 11.5. 2. Препарат по п.1, отличающийся тем, что содержит растворенный продукт лиофилизированного щелочного водного раствора 2-[(2-пиридил) метилсульфинил] бензимидазольного соединения или его соли, обладающих противоязвенной активностью, в водном растворителе без добавления неводного растворителя. 2. The drug according to claim 1, characterized in that it contains the dissolved product of a lyophilized alkaline aqueous solution of a 2 - [(2-pyridyl) methylsulfinyl] benzimidazole compound or a salt thereof having antiulcer activity in an aqueous solvent without the addition of a non-aqueous solvent. 3. Препарат для инъекций по п.1 или 2, отличающийся тем, что 2-[(2-пиридил)метилсульфинил] бензимидазольным соединением или его солью является натриевая соль омепразола. 3. The injection preparation according to claim 1 or 2, characterized in that the 2 - [(2-pyridyl) methylsulfinyl] benzimidazole compound or its salt is the omeprazole sodium salt. 4. Набор для инъекций, содержащий компоненты (a) и (b), где (a) и (b) подбирают таким образом, чтобы pH после растворения (a) в (b) был не менее 9,5 и не более 11,5, где (a) - лиофилизированный продукт щелочного водного раствора 2-[(2-пиридил) метилсульфинил]бензимидазольного соединения или его соли, обладающих противоязвенной активностью, (b) - водный растворитель без добавления неводного растворителя. 4. An injection kit containing components (a) and (b), where (a) and (b) are selected so that the pH after dissolution of (a) in (b) is not less than 9.5 and not more than 11, 5, where (a) is the lyophilized product of an alkaline aqueous solution of 2 - [(2-pyridyl) methylsulfinyl] benzimidazole compound or its salt having anti-ulcer activity, (b) is an aqueous solvent without the addition of a non-aqueous solvent. 5. Набор для инъекций по п.4, отличающийся тем, что 2-[(2-пиридил) метилсульфинил] бензимидазольным соединением или его солью является натриевая соль омепразола. 5. The injection kit according to claim 4, characterized in that the 2 - [(2-pyridyl) methylsulfinyl] benzimidazole compound or its salt is the omeprazole sodium salt.
RU95104936A 1992-07-28 1993-07-15 Injection preparation and a set for injection that contain omeprazol and its analogs RU2126252C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4/201203 1992-07-28
JP20120392 1992-07-28
PCT/JP1993/000998 WO1994002141A1 (en) 1992-07-28 1993-07-15 Injection and injection kit containing omeprazole and its analogs

Publications (2)

Publication Number Publication Date
RU95104936A true RU95104936A (en) 1997-11-27
RU2126252C1 RU2126252C1 (en) 1999-02-20

Family

ID=16437061

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95104936A RU2126252C1 (en) 1992-07-28 1993-07-15 Injection preparation and a set for injection that contain omeprazol and its analogs

Country Status (20)

Country Link
US (1) US5589491A (en)
EP (1) EP0652751B1 (en)
KR (1) KR100258423B1 (en)
AT (1) ATE144421T1 (en)
AU (1) AU674015B2 (en)
CA (1) CA2140347C (en)
CZ (1) CZ284249B6 (en)
DE (1) DE69305642T2 (en)
DK (1) DK0652751T3 (en)
ES (1) ES2093445T3 (en)
FI (1) FI113338B (en)
GR (1) GR3021937T3 (en)
HK (1) HK52397A (en)
HU (1) HU226778B1 (en)
NO (1) NO304098B1 (en)
NZ (1) NZ254237A (en)
RU (1) RU2126252C1 (en)
SG (1) SG52479A1 (en)
SK (1) SK279554B6 (en)
WO (1) WO1994002141A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4324014C2 (en) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Process for the preparation of a preparation reconstitutable in water
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
SE9903831D0 (en) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US7396841B2 (en) 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
US20020064555A1 (en) * 2000-09-29 2002-05-30 Dan Cullen Proton pump inhibitor formulation
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
KR100467100B1 (en) * 2002-03-20 2005-01-24 일양약품주식회사 A process for preparation of injection containing 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1H-pyrrol-1-yl)-1H-benzimidazole or Na salt thereof
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045258A1 (en) * 2003-08-21 2005-10-19 Altana Pharma Ag A PHARMACEUTICAL PRODUCT FOR INJECTION
EP1713476B1 (en) 2003-11-05 2010-05-05 Lyka Labs Limited Process for the preparation of benzimidazoles
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
WO2007091276A2 (en) * 2006-02-10 2007-08-16 Rajasthan Antibiotic Limited Novel crystal form of omeprazol sodium
CN104288175A (en) * 2014-09-17 2015-01-21 大生祥(武汉）中医投资管理有限公司 Novel benzimidazole isomer preparation and preparation method thereof
AU2016367707B2 (en) * 2015-12-08 2022-01-27 Luoda Pharma Limited Methods and compositions for treating gastric ulcers
CN105919953A (en) * 2016-06-27 2016-09-07 峨眉山通惠制药有限公司 Omeprazole sodium composition for injection and production process of omeprazole sodium composition
GB2585628A (en) * 2019-05-08 2021-01-20 Alkaloid Ad Pharmaceutical formulation
CN112807282A (en) * 2021-01-13 2021-05-18 海南葫芦娃药业集团股份有限公司 Omeprazole sodium freeze-dried powder injection and preparation method thereof
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (en) * 1974-05-16 1981-01-26 Haessle Ab PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion
SE7804231L (en) * 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (en) * 1983-02-11 1983-02-11 Haessle Ab NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
SE8301182D0 (en) * 1983-03-04 1983-03-04 Haessle Ab NOVEL COMPOUNDS
JPS6150978A (en) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd Pyridine derivative and preparation thereof
DK399389A (en) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd INJECTABLE SOLUTIONS
EP0382489B1 (en) * 1989-02-10 1994-11-17 Takeda Chemical Industries, Ltd. Use of benzimidazole derivatives as antibacterial agents
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles

Similar Documents

Publication Publication Date Title
RU95104936A (en) INJECTION PRODUCT AND INJECTION KIT CONTAINING OMEPRAZOLE AND ITS ANALOGUES
CA2140347A1 (en) Injection and injection kit containing omeprazole and its analogs
KR950010895A (en) Pharmaceutical composition
DE59106598D1 (en) HIGHLY CONCENTRATED PASTE OF ALPHA SULFOURIC ACID ALKYL ALKALINE METAL SALTS.
CA2057291A1 (en) A stable pharmaceutical composition of human calcitonin
DE3863859D1 (en) STABLE, INJECTABLE SOLUTIONS OF VINCRISTIN SALTS.
IT1227179B (en) PROCEDURE TO SEPARATE AND RECOVER NAPHALENSOLPHONIC ACIDS FROM AQUEOUS SOLUTIONS
FI872637A0 (en) PIPERAZINER DISUBSTITUERADE.
NO884005D0 (en) FLUORATED DERIVATIVES OF AMINO ACIDS SPECIAL FOR USE AS A SURFACTIVE AGENT.
IT8947608A0 (en) THIXOTROPIC AQUEOUS DETERGENT COMPOSITION FOR AUTOMATIC DISHWASHER, AS WELL AS PROCEDURE FOR ITS PREPARATION
DK0431465T3 (en) Aqueous dialysis and rinsing solution
TR27058A (en) 2-azabicyclo (2,2,1) hept-5-ene-2 acetic acid, its derivatives and related compounds, the preparation of the mentioned compounds, and the use of said compounds for the production of n-phosphonomethyl.
IT8920878A0 (en) IMPROVED PROCEDURE FOR THE PREPARATION OF PARAFFIN SULFONIC ACIDS.
NO871157D0 (en) PROCEDURE FOR EXTRACTION OF PARAFFINES WITH ALKAN SULPHONIC ACIDS.
TR23253A (en) USING THE SUELFONOTS AND SUELFUERIC ACID OF THE SUCCESS OF SODIUM SUELFAT, ALKALI SUELFAT OF THE PARAFIN-SULFOXIDATION-REACTION MIX, AND THE SUELFUERIC ACID.
JPS56139414A (en) Stabilizing method of aqueous solution
KR890017259A (en) Method for recovering antibiotics from mother liquor and pharmaceutically acceptable novel salts thereof
KR930017578A (en) Omeprazole oral preparation and preparation method thereof
DK167688A (en) PROCEDURE FOR DEHYDRATIZATION OF Aqueous POLYSACCHARIDE SOLUTIONS
TH3496B (en) Process for the preparation of amphoteric serfactants.
RU99113891A (en) METHOD FOR PREVOCLOSION PREVENTION IN OPERATIONS ON MAIN VESSELS
RU99110034A (en) METHOD FOR PREPARING FRUITS OR VEGETABLES FOR STORAGE
JPS6456616A (en) Antiulcer agent
RU99110033A (en) METHOD FOR PREPARING FRUITS OR VEGETABLES FOR STORAGE
RU99110037A (en) METHOD FOR PREPARING FRUITS OR VEGETABLES FOR STORAGE